Skip to main content
. Author manuscript; available in PMC: 2019 Dec 26.
Published in final edited form as: Circulation. 2018 Dec 11;138(24):2787–2797. doi: 10.1161/CIRCULATIONAHA.118.035627

Table 1.

Clinical characteristics based on timing of ICD placement from last hospitalization for HF.

Overall (N = 81,180) Patients Admitted for HF (N = 11563) HF Admission ≤3 months (N = 6,252) HF Admission >3 months (N = 63,365)

Demographics*
 Age - Mean (SD) 73 (8) 73 (9) 74 (8) 73 (8)
 Sex: Female 28 29 32 27
 Race
  White non-Hispanic 83 75 78 85
  Black non-Hispanic 11 16 15 9
  Hispanic 4 6 5 4
  Other 2 2 2 2
Clinical Characteristics
 NICM 38 40 39 38
 LVEF, Mean (SD) 26 (6) 23 (7) 24 (7) 26 (6)
 NYHA Class
  I 2 1 1 3
  II 31 15 21 36
  III 63 74 73 60
  IV 3 11 5 2
 Atrial fibrillation/flutter 40 48 44 38
 Cerebrovascular Disease 17 20 19 17
 Currently on Dialysis 3 4 4 3
 Diabetes 42 49 49 41
 Chronic Lung Disease 25 34 31 22
 QRS Duration, Median (25th-75th) 127 (103-154) 130 (104-154) 130 (104-156) 126 (102-154)
 Left Bundle Branch Block 35 34 36 35
 BUN, Mean (SD) 26 (14) 32 (16) 31 (15) 25 (12)
 Sodium, Mean (SD) 139 (3) 138 (4) 138 (4) 139 (3)
 Hemoglobin, Mean (SD) 13.0 (1.8) 12.1 (1.9) 12.5 (1.8) 13.2 (1.7)
Procedure
 Implanted Device Type
  Single Chamber 19 16 17 19
  Dual Chamber 27 25 22 27
  CRT-D 55 59 60 53
Discharge Medications
 ACEI 58 55 55 59
 ARB 21 17 20 22
 Beta-Blockers 91 89 90 91
 Hydralazine 5 10 9 4
 Long Acting Nitroglycerin 13 17 17 12
 Digoxin 18 24 22 17
 Diuretics 71 81 86 68
 Aspirin 71 70 70 72
 Statins 70 66 67 71
 Non-Statin 11 8 10 12
 Antiarrhythmic Agents 13 18 16 11
 Channel Blockers 9 8 9 9
 Warfarin 30 34 32 29
 Thienopyridines 24 22 24 24
*

all numbers are calculated using complete cases within each variable

3 months defined as 90 days

Abbreviations: ICD = implantable cardioverter-defibrillation; HF = heart failure; SD = standard deviation; NICM = nonischemic cardiomyopathy; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association; CRT-D = cardiac resynchronization therapy-defibrillator; ACEI = angiotensin converting-enzyme inhibitor; angiotensin receptor blocker.